Back to top

Chuck Royce's Second Quarter 2026 13F: Catalyst Pharmaceuticals Reduction Leads Portfolio Shifts

Chuck Royce's Second Quarter 2026 13F: Catalyst Pharmaceuticals Reduction Leads Portfolio Shifts

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Arcosa, Inc. (ACA)

Dorman Products, Inc. (DORM)

JBT Marel Corporation (JBTM)

Quaker Houghton (KWR)

Manhattan Associates, Inc. (MANH)

MKS Inc. (MKSI)